Toggle Health Problems and D

Low vitamin D associated with COVID-19 problems in NYC hospitals – Feb 2021

An Evaluation of Serum 25-Hydroxy Vitamin D Levels in Patients with COVID-19 in New York City

J Am Coll Nutr. 2021 Feb 19;1-6. doi: 10.1080/07315724.2020.1869626
Elizabeth Marie Gavioli 1 2, Hirotaka Miyashita 2, Omar Hassaneen 1, Evan Siau 2 3


Vitamin D levels were tested at admission or within 2 months before entering the hospital
March and April of 2020
2.2X more likely to need Oxygen support if <20 ng of Vitamin D

COVID-19 treated by Vitamin D - studies, reports, videos

As of Augest 11, 2022, the VitaminDWiki page had:  34 trials 11 trial results,   37 meta-analyses and reviews,   69 observations,   38 recommendations,   55 associations,  89 speculations,  58 videos, 45 Mortality studies   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   26 risk factors are ALL associated with low Vit D,   Recent Virus pages   Fight COVID-19 with 50K Vit D weekly   Vaccines   Take lots of Vitamin D at first signs of COVID   116 COVID Clinical Trials using Vitamin D (08/2022)
5 most-recently changed Virus entries

 Download the PDF from VitaminDWiki
NOTE: The Y axis does not go from 0 to 100%, but rather 75% to 100%



Aim: Deterioration of patients from COVID-19 is associated with cytokine release syndrome attributed to an elevation in pro-inflammatory cytokines. Vitamin D reduces proinflammatory cytokines, and has the possibility of reducing complications from respiratory tract illnesses.

Method: This was a retrospective, observational, cohort study of patients with COVID-19 disease within a New York City Health System. Adult patients were included if they tested positive for SARS-CoV-2, and had a serum 25-hydroxy vitamin D level (25(OH)D) within the three previous months prior to their detected SARS-CoV-2 test. Patients were compared and evaluated based upon their 25(OH)D levels. The primary endpoints were hospitalization, need for oxygen support, and 90-day mortality.

Results: 437 COVID-19 patients were included [67 (IQR: 56-79) years] within this cohort. Deficient plasma 25(OH)D levels (<20 ng/ml) were associated with an increased likelihood of oxygen support [OR:2.23 (95% CI: 1.46-3.44, p = 0.0002)] from COVID-19. Deficient plasma 25(OH)D levels were not independently associated with 90-day mortality or risk of hospitalization. Hospitalization rates (98%), oxygen support (93%), and mortality rates (49%) were highest in patients who had 25(OH)D levels less than 10 ng/ml when compared to other 25(OH)D levels.

Conclusion: Serum 25-hydroxy vitamin D levels may affect the need for oxygen support therapy in patients with COVID-19.

Created by admin. Last Modification: Saturday February 20, 2021 16:35:15 GMT-0000 by admin. (Version 6)

Attached files

ID Name Comment Uploaded Size Downloads
15075 NYC F1 mortality.jpg admin 20 Feb, 2021 16:21 32.33 Kb 212
15074 NYC F1 Oxygen.jpg admin 20 Feb, 2021 16:21 32.66 Kb 184
15073 NYC F1 Hospitalizaion.jpg admin 20 Feb, 2021 16:21 32.29 Kb 187
15072 COVID-19 Vitamin D NYC.pdf PDF 2021 admin 20 Feb, 2021 16:20 980.90 Kb 224
See any problem with this page? Report it (WORKS NOV 2021)